(Q40253260)

English

Mammalian target of rapamycin inhibition induces cell cycle arrest in diffuse large B cell lymphoma (DLBCL) cells and sensitises DLBCL cells to rituximab.

scientific article published on September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16856892%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Mammalian target of rapamycin inhibition induces cell cycle arrest in diffuse large B cell lymphoma (DLBCL) cells and sensitises DLBCL cells to rituximab (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16856892%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

based on heuristic

inferred from title

Ingo Ringshausen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16856892%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Kathrin Wanner

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16856892%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Susanne Hipp

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16856892%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Madlene Oelsner

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16856892%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Christian Bogner

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16856892%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Christian Peschel

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16856892%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Thomas Decker

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16856892%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

0 references

publication date

1 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16856892%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16856892%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

134

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16856892%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16856892%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

475-484

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16856892%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

The TOR pathway: a target for cancer therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

Rituximab in combination with CHOP improves survival in elderly patients with aggressive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

The evolving experience using everolimus in clinical transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

Evidence for cyclin D3 as a novel target of rapamycin in human T lymphocytes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

Mechanisms of resistance to rapamycins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

Targeting mTOR signaling for cancer therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

Rapamycins: mechanism of action and cellular resistance

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70s6k.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

Cyclin A is a functional target of retinoblastoma tumor suppressor protein-mediated cell cycle arrest

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

Phase II study of oral vinorelbine in first-line advanced breast cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

Seventy-two hour continuous infusion flavopiridol in relapsed and refractory mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

Gefitinib and cisplatin-based chemotherapy in non-small-cell lung cancer: simply a bad combination?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

Mammalian target of rapamycin inhibition as therapy for hematologic malignancies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

Small-molecule cyclin-dependent kinase modulators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

Preclinical and clinical development of the cyclin-dependent kinase inhibitor flavopiridol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2006.06210.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40253260&oldid=1513027643"